Abraham I

References (4)

Title : Patient and caregiver outcomes after 6 +\/- 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: the Belgian FExT study - Mets_2007_Curr.Med.Res.Opin_23_2485
Author(s) : Mets T , Vandewoude M , Jacquy J , Deblander A , MacDonald K , Sloesen A , Abraham I
Ref : Curr Med Res Opin , 23 :2485 , 2007
Abstract : Mets_2007_Curr.Med.Res.Opin_23_2485
ESTHER : Mets_2007_Curr.Med.Res.Opin_23_2485
PubMedSearch : Mets_2007_Curr.Med.Res.Opin_23_2485
PubMedID: 17784995

Title : Chronic corticosterone administration dose-dependently modulates Abeta(1-42)- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis - Abraham_2000_J.Neuroendocrinol_12_486
Author(s) : Abraham I , Harkany T , Horvath KM , Veenema AH , Penke B , Nyakas C , Luiten PG
Ref : J Neuroendocrinol , 12 :486 , 2000
Abstract : Abraham_2000_J.Neuroendocrinol_12_486
ESTHER : Abraham_2000_J.Neuroendocrinol_12_486
PubMedSearch : Abraham_2000_J.Neuroendocrinol_12_486
PubMedID: 10844576

Title : Propionyl-IIGL tetrapeptide antagonizes beta-amyloid excitotoxicity in rat nucleus basalis - Harkany_1999_Neuroreport_10_1693
Author(s) : Harkany T , Abraham I , Laskay G , Timmerman W , Jost K , Zarandi M , Penke B , Nyakas C , Luiten PG
Ref : Neuroreport , 10 :1693 , 1999
Abstract : Harkany_1999_Neuroreport_10_1693
ESTHER : Harkany_1999_Neuroreport_10_1693
PubMedSearch : Harkany_1999_Neuroreport_10_1693
PubMedID: 10501559

Title : N-Methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against beta-amyloid neurotoxicity - Harkany_1999_Neurobiol.Dis_6_109
Author(s) : Harkany T , Mulder J , Sasvari M , Abraham I , Konya C , Zarandi M , Penke B , Luiten PG , Nyakas C
Ref : Neurobiol Dis , 6 :109 , 1999
Abstract : Harkany_1999_Neurobiol.Dis_6_109
ESTHER : Harkany_1999_Neurobiol.Dis_6_109
PubMedSearch : Harkany_1999_Neurobiol.Dis_6_109
PubMedID: 10343326